News und Analysen

Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the

Here's a little twist for those who like to focus on fundamentals and economic forces when predicting the stock market. When inflation runs hot, it benefits stocks overall, and the opposite is

Getting income from stock investments is why many invest in certain companies. It can provide a stable cash stream while offering the benefit of potential appreciation in stock price. However

Momentum and value investing are two distinct investment approaches with their own strengths and risks. While momentum investing relies on following existing price trends, value investing focuses

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like Duchenne muscular dystrophy (DMD). Capricor’s stock

With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are

As a new regime and phase begin for the market and economy, after the FED cut interest rates by a surprising 50bps last Wednesday, several new opportunities and sector bull and bear markets might

Now that the market is shifting due to the new path the Federal Reserve (the Fed) has undertaken recently, cutting interest rates and starting a new monetary policy easing cycle, investors need to

The Federal Reserve rate cuts have sent the market up, but some stocks are rising more than others. That includes small pharmaceutical companies like Wave Life Sciences (NASDAQ: WVE), whose

With the Federal Reserve kickstarting a new rate-cutting cycle, dividend stocks have become even more attractive. On Wednesday, the Fed made a hefty 50 basis points cut, surprising many who had

Viking Therapeutics Inc. (NASDAQ: VKTX), a clinical-stage biotechnology company with a market cap approaching $7 billion, is turning heads in 2024. Year to date, the stock has surged an

After seven years, over 3,350 patent and patent-pending claims, and more than $1 billion, AST SpaceMobile Inc. (NASDAQ: ASTS) finally launched its Block 1 first five Bluebird satellites on

Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. The company has a vast portfolio of

Summit Therapeutics Inc. (NASDAQ: SMMT) has seen a meteoric rise this month, surging over 106% after releasing positive clinical trial results for its experimental cancer therapy. Year-to-date

After a prolonged consolidation and downtrend following the pandemic-driven surge, the biotechnology sector is readying for a potential breakout and shifting its narrative. Represented by the

Alnylam Pharmaceuticals (NASDAQ: ALNY) stock price action has been volatile but is uptrending and has gained 100% in the last two years. The uptrend is driven by increasing expectations for

Investors often think of the start of autumn as a time of increased volatility for the market due to a phenomenon known as the "September Effect," a historically-verifiable trend in which the

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases an aging population

Merck & Co., Inc. (NYSE: MRK) is one of the largest pharmaceutical firms in the world. The firm ranks fourth behind giants like Eli Lilly (NYSE :LLY) and Novo Nordisk (NYSE: NVO), with a market